PEAK6 Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

PEAK6 Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-95,900	Closed	-$4.14M	–	5805
2015 Q3	$4.14M	Buy	95,900 +15,568	+19%	+$657K	0.02%	1030
2015 Q2	$3.4M	Buy	+80,332	New	+$3.39M	0.02%	1090
2014 Q4	–	Sell	-21,684	Closed	-$766K	–	5603
2014 Q3	$759K	Buy	21,684 +10,862	+100%	+$372K	0.01%	2080
2014 Q2	$356K	Buy	10,822 +8,514	+369%	+$291K	﹤0.01%	2640
2014 Q1	$85K	Buy	+2,308	New	+$84.7K	﹤0.01%	4053

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

PEAK6 Group's WX Position: Q4 2015 in Review

PEAK6 Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 95,900 shares — an estimated $4.14M sold.

PEAK6 Group first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $4.14M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

PEAK6 Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 95,900 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.14M.
PEAK6 Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
PEAK6 Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.14M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.